Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa. Num. Pages Manejo clínico de las hiperprolactinemias. Clinical management of hyperprolactinemia. Visits. Download PDF. La frecuencia de hiperprolactinemia en esta entidad es del 13 al 59% y los . Artículo. B. Farzati,G. Mazziotti,G. Cuomo,M. Ressa,F. Sorvillo,G. Amato.

Author: Nekree Zulkikree
Country: Bolivia
Language: English (Spanish)
Genre: Business
Published (Last): 2 October 2017
Pages: 296
PDF File Size: 1.73 Mb
ePub File Size: 19.27 Mb
ISBN: 464-4-87001-277-1
Downloads: 95991
Price: Free* [*Free Regsitration Required]
Uploader: Jumuro

Malignant prolactinoma should be suspected in patients with no response to drug treatment or recurrence after surgery. It quickly resolves with discontinuation of the drug. The main biological action of prolactin is hiperprolactjnemia and maintaining lactation. J Endocrinol Invest, 20pp. Print Send to a friend Export reference Mendeley Statistics.

Overt hypothyroidism is characterized by elevated serum TSH and decreased peripheral thyroid hormone levels, with etiologies including autoimmune thyroid gland failure, iatrogenic failure radioactive iodine, external beam radiationand thyroidectomy. Prolonged hypoestrogenism secondary to hyperprolactinemia may result in osteopenia.

Alteraciones endocrinas en la esclerosis sistémica | Reumatología Clínica

Clin Endocrinol Oxf37pp. Read this article in English. Women with amenorrhea may be treated with estrogens and should be measured for PRL levels annually. Although the cumulative risk dose has not yet been established, we suggest that performing routine echocardiographic controls in the first few years of treatment in patients receiving cabergoline 1—2 mg weekly is not indispensable3 unless advised by the presence of coexistent clinical factors.

However, lactation is inhibited by the high levels of estrogen and progesterone during pregnancy. Of the pituitary hormones secreted by the anterior pituitary, disorders of prolactin, GH, and ACTH may be associated hiperprolctinemia cardiac disease.


A new complication of the ergot derivative dopamine agonists. Features of Amiodarone-Induced Thyroid Dysfunction. Maximum dose that can be given is 1 mg twice a week. Dynamic tests TRH, l -dopa, domperidone, etc. Rev Med Chil,pp.

[Current diagnosis and treatment of hyperprolactinemia].

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client hiperprolatcinemia through the analyses of navigation customer behavior. Characteristics and available dosage forms of dopamine agonists. Glucocorticoid replacement at the lowest therapeutic dosage is suggested as treatment of GRA.

Biomed Pharmacother, 60pp. Symptoms derived from hyperprolactinemia which represent indications for treatment include: J Rheumatol, 33pp.

The Endocrine System and the Heart: A Review | Revista Española de Cardiología (English Edition)

Pituitary, 13pp. In this review, we discuss the epidemiology, diagnosis, and management of disorders of the pituitary, thyroid, parathyroid, and adrenal glands, with respect to the impact of articklo dysfunction on the cardiovascular system. Treatment guidelines recommend unilateral laparoscopic adrenalectomy in patients with documented unilateral PA, or medical treatment with a mineralocorticoid receptor antagonist spironolactone or eplerenone in nonsurgical patients.

Patients who have symptomatic hyperparathyroidism should be offered surgical management with removal of hyperfunctioning parathyroid adenoma s. Hyperprolactinemia is considered to be idiopathic when its secondary causes have been hipetprolactinemia out and pituitary MRI is normal. Disorders of the anterior pituitary and hypothalamus.

Previous article Next article. Hyperprolactinemia may therefore be not only due to tumor hypersecretion, but also because of various physiological and pathological hiperprolactineia, and also due to multiple drugs which alter dopamine production, transport, or action. T 4 replacement resolves these functional abnormalities, improving both diastolic and systolic function.



In postmenopausal women, the clinical signs are mainly due to the mass effect of the adenoma. No scientific evidence is available to support the recommendation by some authors to discontinue dopamine agonists before radiotherapy is administered to improve its results. Clin Endocrinol Oxf61pp. Some of the common causes are listed in Figure 1. New concerns about old drugs: Histamine has a predominantly stimulatory effect due to the inhibition of the dopaminergic system.

Resumen Hiperprolactinenia hiperprolactinemia puede deberse tanto a adenomas hipofisarios que secretan prolactina prolactinomas como a tumores selares no funcionantes denominados “seudoprolactinomas”. Inhibitory effects of antivascular endothelial growth factor strategies hiperprolactineemia experimental dopamine-resistant prolactinomas.

The cause of resistance is not fully known, but a decreased number of D2 receptors have hiperprolactinemiaa reported, among other mechanisms. The natural history of untreated hyperprolactinemia: It may however be considered if the mother wants to breast-feed her child and no tumor size increase has been found during pregnancy.

October Pages Subclinical hyperthyroidism is defined by low or undetectable serum TSH and normal peripheral free thyroid hormone levels. In the short term, hyperthyroidism may be associated with improved diastolic function.